ConductScience.org, home

Paper48206

Physiologic basis for hormonal theapy in carcinoma of the prostate.

Walsh PC. Urol Clin North Am, 1975. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. Physiologic basis for hormonal theapy in carcinoma of the prostate. Papers, record 48206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/48206

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Physiologic basis for hormonal theapy in carcinoma of the prostate.
PubMed
Journal
Urol Clin North Am
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
3.36
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Walsh PCP C

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HormonesMajor topic
Prostatic NeoplasmsMajor topic
Adrenalectomy
Androgen Antagonists
Androgens
Animals
Castration
Chemical Phenomena
Chemistry
Chlormadinone Acetate
Cyproterone
Depression, Chemical
Dihydrotestosterone
Estrogens
Humans
Hypophysectomy
Luteinizing Hormone
Male
Prostate
Testosterone

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
28123517Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.Oncol Lett2017https://conductscience.org/library/papers/28123517PubMed
24566948Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?Eur J Nucl Med Mol Imaging2014https://conductscience.org/library/papers/24566948PubMed
23564037Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.Eur J Nucl Med Mol Imaging2013https://conductscience.org/library/papers/23564037PubMed
22110986An update on the changing indications for androgen deprivation therapy for prostate cancer.Prostate Cancer2011https://conductscience.org/library/papers/22110986PubMed
21981434Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care.Drug Saf2011https://conductscience.org/library/papers/21981434PubMed
11057778'Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate.Int Urol Nephrol2000https://conductscience.org/library/papers/11057778PubMed
7531602Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up.Ann Surg Oncol1994https://conductscience.org/library/papers/7531602PubMed
7066277Prostatic carcinoma metastatic to choroid.Br J Ophthalmol1982https://conductscience.org/library/papers/7066277PubMed
4045880Endocrine treatment of prostatic cancer.J R Soc Med1985https://conductscience.org/library/papers/4045880PubMed
3280813Update in cancer chemotherapy: genitourinary tract cancer, Part 3: Cancer of the prostate.J Natl Med Assoc1988https://conductscience.org/library/papers/3280813PubMed
2939240Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.J R Soc Med1986https://conductscience.org/library/papers/2939240PubMed
2734984Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy.Urol Res1989https://conductscience.org/library/papers/2734984PubMed
1729258Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.J Cancer Res Clin Oncol1992https://conductscience.org/library/papers/1729258PubMed
1692896[Problems and principles of hormone therapy of advanced prostate cancer].Klin Wochenschr1990https://conductscience.org/library/papers/1692896PubMed
1615580Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.Urol Res1992https://conductscience.org/library/papers/1615580PubMed
1289272The influence of bilateral orchiectomy on volume changes of the prostate in men with advanced prostatic cancer--the predictive value.Int Urol Nephrol1992https://conductscience.org/library/papers/1289272PubMed
73547Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.J Clin Invest1978https://conductscience.org/library/papers/73547PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/48206

GET https://conductscience.org/api/papers/v1/48206/authors